At a glance
ClinicalIndex Comparison RecordN/ACompleted· 134 enrolled
Drug / intervention
Use of procalcitonin as biomarker to guide therapyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Measuring Serum Procalcitonin Levels on Duration of Antimicrobial Therapy in Critical Care Patients With Suspected Pneumonia
In Brief
A clinical study evaluating Use of procalcitonin as biomarker to guide therapy for Pneumonia. Completed, enrolled 134 participants across 1 site.
Detailed Summary
The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedFeb 2013
Primary CompletionMar 2013
Study CompletionJun 2013
TodayJul 2026
First PostedFeb 11, 2013
Enrollment StartFeb 1, 2013
Primary CompletionMar 1, 2013
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 13.4 years ago
Interventions
Use of procalcitonin as biomarker to guide therapyother